Showing results (31-40 of 556) with videos related to
Sort By:
Pageof 56
The Lancet. Neurology|June 20, 2018
Network imaging biomarkers: insights and clinical applications in Parkinson's diseaseKatharina A Schindlbeck, David EidelbergNeuroimage|October 26, 2010
Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issuesPhoebe G Spetsieris, David EidelbergProgress in Brain Research|October 5, 2010
Abnormal metabolic brain networks in Parkinson's disease from blackboard to bedsideChris C Tang, David EidelbergNeuroimage|December 31, 2011
Functional brain networks and abnormal connectivity in the movement disordersKathleen L Poston, David EidelbergPET Clinics|August 7, 2010
FDG PET in the Evaluation of Parkinson's DiseaseKathleen L Poston, David EidelbergNeurobiology of Disease|November 18, 2008
Network biomarkers for the diagnosis and treatment of movement disordersKathleen L Poston, David EidelbergNeuroimage|November 27, 2020
Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson's diseasePhoebe G Spetsieris, David EidelbergNeuroimage. Clinical|September 3, 2023
Parkinson's disease progression: Increasing expression of an invariant common core subnetworkPhoebe G Spetsieris, David EidelbergJournal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 6, 2006
Modified high-performance liquid chromatography with electrochemical detection method for plasma measurement of levodopa, 3-O-methyldopa, dopamine, carbidopa and 3,4-dihydroxyphenyl acetic acidMorvarid Karimi, Juanita L Carl, Susan Loftin, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2003
Botulinum toxin B reduces sialorrhea in parkinsonismBrad A Racette, Laura Good, Sandy Sagitto, et al.Pageof 56